Compare Expeditors International of Wshngtn Inc (EXPD) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expeditors International of Wshngtn Inc vs Novo Nordisk A/S — how do they compare? Expeditors International of Wshngtn Inc trades at $177.4 (market cap $23.04B), while Novo Nordisk A/S trades at $45.95 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 9× Expeditors International of Wshngtn Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| EXPD | NVO | |
|---|---|---|
Market Cap | $23.04B | $207.85B |
Sector | Industrials | Health |
52-Week High | $182.80 | $63.98 |
52-Week Low | $113.13 | $35.29 |
Enterprise Value | $22.57B | $222.55B |
Dividend Yield | 0.91% | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Expeditors International of Wshngtn Inc
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
